126 related articles for article (PubMed ID: 15705356)
1. Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.
Smesny S; Kinder D; Willhardt I; Rosburg T; Lasch J; Berger G; Sauer H
Biol Psychiatry; 2005 Feb; 57(4):399-405. PubMed ID: 15705356
[TBL] [Abstract][Full Text] [Related]
2. [Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia].
Gattaz WF; Nevalainen TJ; Kinnunen PK
Fortschr Neurol Psychiatr; 1990 Apr; 58(4):148-53. PubMed ID: 2354835
[TBL] [Abstract][Full Text] [Related]
3. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.
Ross BM; Hudson C; Erlich J; Warsh JJ; Kish SJ
Arch Gen Psychiatry; 1997 May; 54(5):487-94. PubMed ID: 9152103
[TBL] [Abstract][Full Text] [Related]
4. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
[TBL] [Abstract][Full Text] [Related]
5. An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia.
Xu C; Yang X; Sun L; Yang T; Cai C; Wang P; Jiang J; Qing Y; Hu X; Wang D; Wang P; Cui G; Zhang J; Li Y; Ji F; Liu C; Wan C
Psychiatry Res; 2019 Mar; 273():782-787. PubMed ID: 31207866
[TBL] [Abstract][Full Text] [Related]
6. Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12.
Smesny S; Kunstmann C; Kunstmann S; Willhardt I; Lasch J; Yotter RA; Proffitt TM; Kerr M; Marculev C; Milleit B; Milleit C; Nenadic I; Amminger P; McGorry PD; Sauer H; Berger GE
World J Biol Psychiatry; 2011 Dec; 12(8):598-607. PubMed ID: 21143005
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.
Gattaz WF; Köllisch M; Thuren T; Virtanen JA; Kinnunen PK
Biol Psychiatry; 1987 Apr; 22(4):421-6. PubMed ID: 3567258
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
[TBL] [Abstract][Full Text] [Related]
9. Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophrenia.
Lasch J; Willhardt I; Kinder D; Sauer H; Smesny S
Clin Chem Lab Med; 2003 Jul; 41(7):908-14. PubMed ID: 12940517
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients.
Albers M; Meurer H; Märki F; Klotz J
Pharmacopsychiatry; 1993 May; 26(3):94-8. PubMed ID: 8415900
[TBL] [Abstract][Full Text] [Related]
11. Elevated PLA2 activity in schizophrenics and other psychiatric patients.
Noponen M; Sanfilipo M; Samanich K; Ryer H; Ko G; Angrist B; Wolkin A; Duncan E; Rotrosen J
Biol Psychiatry; 1993 Nov; 34(9):641-9. PubMed ID: 8292693
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
[TBL] [Abstract][Full Text] [Related]
13. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology.
Xiu MH; Chen DC; Wang D; Zhang K; Dong A; Tang W; Zhang F; Liu LJ; Liu JH; Liu HB; Yang FD; Kosten TR; Zhang XY
J Psychiatr Res; 2012 Aug; 46(8):1093-8. PubMed ID: 22647522
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
15. Serum calcium-independent phospholipase A2 activity in bipolar affective disorder.
Ross BM; Hughes B; Kish SJ; Warsh JJ
Bipolar Disord; 2006 Jun; 8(3):265-70. PubMed ID: 16696828
[TBL] [Abstract][Full Text] [Related]
16. Increased phospholipase A2 activity in schizophrenia with absent response to niacin.
Tavares H; Yacubian J; Talib LL; Barbosa NR; Gattaz WF
Schizophr Res; 2003 May; 61(1):1-6. PubMed ID: 12648730
[TBL] [Abstract][Full Text] [Related]
17. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.
Zhang XY; Chen DC; Xiu MH; Wang F; Qi LY; Sun HQ; Chen S; He SC; Wu GY; Haile CN; Kosten TA; Lu L; Kosten TR
Schizophr Res; 2009 Sep; 113(2-3):151-7. PubMed ID: 19540723
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells.
Song Y; Wilkins P; Hu W; Murthy KS; Chen J; Lee Z; Oyesanya R; Wu J; Barbour SE; Fang X
Biochem J; 2007 Sep; 406(3):427-36. PubMed ID: 17555408
[TBL] [Abstract][Full Text] [Related]
19. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia.
Barbosa NR; Junqueira RM; Vallada HP; Gattaz WF
Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):340-3. PubMed ID: 17629734
[TBL] [Abstract][Full Text] [Related]
20. Allelic association analysis of phospholipase A2 genes with schizophrenia.
Junqueira R; Cordeiro Q; Meira-Lima I; Gattaz WF; Vallada H
Psychiatr Genet; 2004 Sep; 14(3):157-60. PubMed ID: 15318030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
